ASM Microbe

The latest news from ASM Microbe, with clinician perspectives, interviews and insight, plus archives of past meetings.
SPONSORED CONTENT
September 11, 2013
1 min read
Save

Lower vancomycin dose efficacious in C. difficile

Lower vancomycin dose efficacious in C. difficile

DENVER — A low dose of oral vancomycin for the treatment of Clostridium difficile was similar in efficacy to a high-dose treatment regimen, data presented here at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy suggest.

SPONSORED CONTENT
September 11, 2013
1 min read
Save

MALDI-TOF significantly decreased time to organism identification

MALDI-TOF significantly decreased time to organism identification

DENVER — Using matrix-assisted laser desorption ionization time-of-flight mass spectrometry, or MALDI-TOF, decreased the time necessary to identify the organism causing bloodstream infections and may improve time to appropriate antibiotic treatment, according to data presented here at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 11, 2013
1 min read
Save

Vaccinations increased serotype protection in children with idiopathic nephrotic syndrome

Vaccinations increased serotype protection in children with idiopathic nephrotic syndrome

DENVER — Administration of the 13-valent pneumococcal conjugate vaccine increased protection against Streptococcus pneumoniae that induce higher titers and better serotype coverage in patients with idiopathic nephrotic syndrome, researchers reported here at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 11, 2013
2 min read
Save

Herpes zoster vaccinations low among older adults

Herpes zoster vaccinations low among older adults

DENVER — Herpes zoster vaccination coverage across the United States remains relatively low among adults aged at least 50 years, according to data presented here at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 11, 2013
2 min read
Save

Herpes zoster vaccinations low among older adults

Herpes zoster vaccinations low among older adults

DENVER — Herpes zoster vaccination coverage across the United States remains relatively low among adults aged at least 50 years, according to data presented here at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 10, 2013
1 min read
Save

TMP-SMX, clindamycin effective treatment of uncomplicated SSTIs

TMP-SMX, clindamycin effective treatment of uncomplicated SSTIs

DENVER — Clindamycin and trimethoprim/sulfamethoxazole were similar in efficacy for primary treatment of uncomplicated skin and soft tissue infections, researchers reported during the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 10, 2013
1 min read
Save

Oritavancin efficacy similar to vancomycin for treating ABSSSI

Oritavancin efficacy similar to vancomycin for treating ABSSSI

DENVER — A single-dose of investigational oritavancin had similar efficacy compared with 7 to 10 days of use of vancomycin, researchers reported here at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 10, 2013
1 min read
Save

Similar efficacy found between tedizolid, linezolid

Similar efficacy found between tedizolid, linezolid

DENVER — A 6-day course of once-daily tedizolid had similar efficacy compared with linezolid every 12 hours for 10 days for the treatment of patients with acute bacterial skin and skin structure infections, according to findings presented at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 10, 2013
2 min read
Save

Breath test identified metabolites associated with fungal pneumonia

Breath test identified metabolites associated with fungal pneumonia

DENVER — A new diagnostic method using a breath test that detected specific metabolites accurately identified patients with pneumonia caused invasive fungal disease, according to data presented at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.

SPONSORED CONTENT
September 10, 2013
1 min read
Save

Test identified ESBL-producing bacteria quickly

Test identified ESBL-producing bacteria quickly

DENVER — The use of an extended-spectrum beta-lactamase, or ESBL, NDP test accurately identified 100% of blood cultures with Enterobacteriaceae that produced ESBL in 20 minutes, according to a presentation here at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy.